MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Update on COVID-19 ARDS Trial, page-441

  1. 7,779 Posts.
    lightbulb Created with Sketch. 1337
    Why are you convinced the tech is good? Why is this the fault of trial design, or the FDA or big pharma, as others keep mentioning?

    Is that why MSC therapies traditionally fail phase three trials? MSB is not the first company to try this.

    I'm not saying it doesn't work. I'm just wondering why, at this stage, people are so convinced it does.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.19
Change
0.085(7.69%)
Mkt cap ! $1.358B
Open High Low Value Volume
$1.10 $1.20 $1.09 $13.21M 11.37M

Buyers (Bids)

No. Vol. Price($)
1 15000 $1.19
 

Sellers (Offers)

Price($) Vol. No.
$1.19 75212 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.